Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.41 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3018658 | 1.00 | F2 (0.59) | F2LMNATSHRTDP1ALDH1A1 | |
| SCHEMBL5974780 | 0.98 | F2 (0.57) | F2LMNATSHRTDP1ALDH1A1 | |
| SCHEMBL18989302 | 0.92 | LMNA (0.50) | F2LMNATSHRTDP1ALDH1A1 | |
| SCHEMBL6684579 | 0.82 | LMNA (0.67) | F2LMNATSHRTDP1ALDH1A1 | |
| SCHEMBL6675159 | 0.80 | LMNA (0.64) | F2LMNATSHRTDP1ALDH1A1 | |
| SCHEMBL3018655 | 0.80 | F2 (0.52) | F2LMNATSHRTDP1ALDH1A1 | |
| Benzoyl Peroxide SCHEMBL28829336 | 0.80 | LMNA (0.71) | F2LMNATSHRTDP1ALDH1A1 | |
| SCHEMBL6261808 | 0.78 | BCAT1 (0.43) | TSHRTDP1ALDH1A1MAPTHSD11B1 | |
| SCHEMBL6871550 | 0.78 | LMNA (0.61) | F2LMNATSHRTDP1ALDH1A1 | |
| SCHEMBL20885264 | 0.78 | LMNA (0.61) | F2LMNATSHRTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200297594-A1 | Hydrogen Peroxide Booster System for Enhanced Teeth Whitening | COLGATE-PALMOLIVE COMPANY (US) | 2020-09-24 | — | — | US | claimed |
| US-20180369087-A1 | Hydrogen Peroxide Booster System for Enhanced Teeth Whitening | COLGATE-PALMOLIVE COMPANY (US) | 2018-12-27 | — | — | US | claimed |
| EP-3383503-A1 | HYDROGEN PEROXIDE BOOSTER SYSTEM FOR ENHANCED TEETH WHITENING | Colgate-Palmolive Company (US) | 2018-10-10 | — | — | EP | claimed |
| WO-2017105455-A1 | HYDROGEN PEROXIDE BOOSTER SYSTEM FOR ENHANCED TEETH WHITENING | COLGATE-PALMOLIVE COMPANY (US) | 2017-06-22 | — | — | WO | claimed |
| US-8431519-B2 | Co-granulates of bleach activator-peroxide compounds | OCI CHEMICAL CORP. (US) | 2013-04-30 | — | — | US | claimed |
| US-20100207062-A1 | CO-GRANULATES OF BLEACH ACTIVATOR-PEROXIDE COMPOUNDS | OCI CHEMICAL CORPORATION (US) | 2010-08-19 | — | — | US | claimed |
| US-7709437-B2 | Co-granulates of bleach activator-peroxide compounds | OCI CHEMICAL CORP. (US) | 2010-05-04 | — | — | US | claimed |
| EP-2021454-A1 | CO-GRANULATES OF BLEACH ACTIVATOR-PEROXIDE COMPOUNDS | OCI Chemical Corporation (US) | 2009-02-11 | — | — | EP | claimed |
| WO-2007127641-A1 | CO-GRANULATES OF BLEACH ACTIVATOR-PEROXIDE COMPOUNDS | OCI CHEMICAL CORPORATION (US) | 2007-11-08 | — | — | WO | claimed |
| US-20070252107-A1 | Co-granulates of bleach activator-peroxide compounds | OCI CHEMICAL CORPORATION | 2007-11-01 | — | — | US | claimed |
| EP-1286959-B1 | EXTRACTIVE SOLUTION CRYSTALLIZATION OF CHEMICAL COMPOUNDS | EASTMAN CHEM CO (US) | 2004-12-22 | — | — | EP | claimed |
| EP-1286959-A2 | EXTRACTIVE SOLUTION CRYSTALLIZATION OF CHEMICAL COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2003-03-05 | — | — | EP | claimed |
| US-6500973-B2 | SOLVENT EXTRACTION OF PHENYL ESTER | EASTMAN CHEMICAL COMPANY | 2002-12-31 | — | — | US | claimed |
| US-20020035284-A1 | Extractive solution crystallization of chemical compounds | EASTMAN CHEMICAL COMPANY | 2002-03-21 | — | — | US | claimed |
| WO-2001094302-A2 | EXTRACTIVE SOLUTION CRYSTALLIZATION OF CHEMICAL COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2001-12-13 | — | — | WO | claimed |
| JP-4285699-A | — | — | None | — | — | JP | disclosed |
| US-20240057589-A1 | EFFERVESCENT SOLID DOSAGE FORM COMPOSITIONS CONTAINING ENVIRONMENTALLY SAFER ANTI-MICROBIAL COMPONENTS | CHEMLINK LABORATORIES, LLC | 2024-02-22 | — | — | US | disclosed |
| EP-0481792-A1 | Detergent compositions in tablet form | UNILEVER PLC (GB) | 1992-04-22 | — | — | EP | disclosed |
| US-4578206-A | SUFRACTANT, PEROXIDE, PERACID PRECURSOR, ALKALI METAL CARBONATE, MANGANESE IONS | LEVER BROTHERS COMPANY (US) | 1986-03-25 | — | — | US | disclosed |
| EP-0132860-A1 | Detergent bleach compositions | UNILEVER N.V. (NL) | 1985-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200297594-A1 | Hydrogen Peroxide Booster System for Enhanced Teeth Whitening | GPX4, GPX1, PRDX3 | F2 3067/4885LMNA 2304/4885TSHR 2836/4885 |
| US-20180369087-A1 | Hydrogen Peroxide Booster System for Enhanced Teeth Whitening | CAT, GPX4, LPO | F2 2549/4885LMNA 2464/4885TSHR 2794/4885 |
| US-20020035284-A1 | Extractive solution crystallization of chemical compounds | HPSE, HAAO, APEH | F2 3702/4885LMNA 3624/4885TSHR 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.